UA93901C2 - Вакцина против микоплазмы и вируса prrs - Google Patents

Вакцина против микоплазмы и вируса prrs

Info

Publication number
UA93901C2
UA93901C2 UAA200812024A UAA200812024A UA93901C2 UA 93901 C2 UA93901 C2 UA 93901C2 UA A200812024 A UAA200812024 A UA A200812024A UA A200812024 A UAA200812024 A UA A200812024A UA 93901 C2 UA93901 C2 UA 93901C2
Authority
UA
Ukraine
Prior art keywords
prrs
vaccine against
vaccine
against mycoplasma
immunogenic
Prior art date
Application number
UAA200812024A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Христа Сибила Дрекслер
Мартен Витвлит
Original Assignee
Интервет Интернешонал Б.B.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Интервет Интернешонал Б.B. filed Critical Интервет Интернешонал Б.B.
Publication of UA93901C2 publication Critical patent/UA93901C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
UAA200812024A 2006-04-10 2007-04-06 Вакцина против микоплазмы и вируса prrs UA93901C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112444 2006-04-10

Publications (1)

Publication Number Publication Date
UA93901C2 true UA93901C2 (ru) 2011-03-25

Family

ID=37114256

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200812024A UA93901C2 (ru) 2006-04-10 2007-04-06 Вакцина против микоплазмы и вируса prrs

Country Status (7)

Country Link
CN (1) CN101420975B (de)
AT (1) ATE535253T1 (de)
BR (1) BRPI0710550A2 (de)
DK (1) DK2007419T3 (de)
ES (1) ES2377576T3 (de)
RU (1) RU2408386C2 (de)
UA (1) UA93901C2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013526866A (ja) * 2010-05-19 2013-06-27 バイオプロパティーズ ピーティーワイ リミテッド 弱毒化マイコプラズマに関する方法
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
WO2020127730A1 (en) 2018-12-20 2020-06-25 Intervet International B.V. Prime-boost vaccination regimen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
WO2005112995A1 (en) * 2004-04-26 2005-12-01 Choongang Vaccine Laboratory Co., Ltd. Inactivated mixed vaccine for porcine respiratory disease and the method of manufacturing thereof

Also Published As

Publication number Publication date
RU2408386C2 (ru) 2011-01-10
DK2007419T3 (da) 2012-03-19
CN101420975A (zh) 2009-04-29
ES2377576T3 (es) 2012-03-29
RU2008144180A (ru) 2010-05-20
BRPI0710550A2 (pt) 2011-08-16
ATE535253T1 (de) 2011-12-15
CN101420975B (zh) 2012-06-27

Similar Documents

Publication Publication Date Title
CY1120347T1 (el) Εμβολιο ιου ερπητα ζωστηρα
MY152149A (en) Prevention and treatment of sub-clinical pcvd
EA201100268A1 (ru) Вакцина
CL2013002379A1 (es) Virus del sindrome reproductor y respiratorio porcino (prrsv); procedimiento para la preparacion del prrsv atenuado vivo; vacuna que lo comprende y su procedimiento de preparacion; y procedimiento para inmunizar cerdos contra el sindrome reproductor y respiratorio porcino.
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
BRPI0606539A2 (pt) vacinas aperfeiçoadas contra a prrs
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
IN2012DN02736A (de)
MX2019003004A (es) Composiciones para inmunizacion contra staphylococcus aureus.
PH12013502442A1 (en) Inactivated dengue virus vaccine
WO2010025109A8 (en) Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
GB201101665D0 (en) Immunogenic compositions
WO2012027365A3 (en) Targeted multi-epitope dosage forms for induction of an immune response to antigens
WO2007120673A3 (en) Immunogenic wt-1 peptides and methods of use thereof
AU2007224734C1 (en) Live attenuated Bordetella strains as a single dose vaccine against whooping cough
MX2009008928A (es) Composiciones que comprenden conjugados de polisacaridos y su uso como vacunas.
PH12012500950A1 (en) Oral compositions containing extracts of myristica fragrans and related methods
MX2013010620A (es) Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
NZ630868A (en) Acellular pertussis vaccine
CA2646574A1 (en) Vaccine against mycoplasma and prrsv
UA93901C2 (ru) Вакцина против микоплазмы и вируса prrs
MX2010003719A (es) Vacuna de mycoplasma bovis y metodos de uso de la misma.
SG194167A1 (en) Oral care composition for treating dry mouth
BR112016012393A2 (pt) Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado